Kalemkerian GP - Search Results

1

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.

Rudin CM, Awad MM, Navarro A, Gottfried M, Peters S, Csőszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gümüş M, Kato T, Kalemkerian GP, Luo Y, Ebiana V, Pietanza MC, Kim HR; KEYNOTE-604 Investigators. Rudin CM, et al. Among authors: kalemkerian gp. J Clin Oncol. 2020 Jul 20;38(21):2369-2379. doi: 10.1200/JCO.20.00793. Epub 2020 May 29. J Clin Oncol. 2020. PMID: 32468956 Free PMC article. Clinical Trial.

2

Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database.

Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP. Ramalingam S, et al. Among authors: kalemkerian gp. J Clin Oncol. 1998 Feb;16(2):651-7. doi: 10.1200/JCO.1998.16.2.651. J Clin Oncol. 1998. PMID: 9469354

3

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.

Kalemkerian GP, Jiroutek M, Ettinger DS, Dorighi JA, Johnson DH, Mabry M. Kalemkerian GP, et al. Cancer. 1998 Sep 15;83(6):1102-8. doi: 10.1002/(sici)1097-0142(19980915)83:6<1102::aid-cncr8>3.0.co;2-9. Cancer. 1998. PMID: 9740074 Clinical Trial.

4

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.

Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Lung Cancer. 1999 Sep;25(3):175-82. doi: 10.1016/s0169-5002(99)00060-4. Lung Cancer. 1999. PMID: 10512128 Clinical Trial.

5

A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Wozniak AJ, Cummings G, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Cancer Invest. 2000;18(1):1-5. doi: 10.3109/07357900009023055. Cancer Invest. 2000. PMID: 10701360 Clinical Trial.

6

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

Krug LM, Miller VA, Kalemkerian GP, Kraut MJ, Ng KK, Heelan RT, Pizzo BA, Perez W, McClean N, Kris MG. Krug LM, et al. Among authors: kalemkerian gp. Ann Oncol. 2000 Feb;11(2):227-8. doi: 10.1023/a:1008349209956. Ann Oncol. 2000. PMID: 10761761 Free article. Clinical Trial. No abstract available.

7

Therapeutic advances in small cell lung cancer.

Worden FP, Kalemkerian GP. Worden FP, et al. Among authors: kalemkerian gp. Expert Opin Investig Drugs. 2000 Mar;9(3):565-79. doi: 10.1517/13543784.9.3.565. Expert Opin Investig Drugs. 2000. PMID: 11060696 Review.

8

Unusual presentations of lung cancer: Case 1. Diabetes insipidus as the initial manifestation of non-small-cell lung cancer.

Reddy P, Kalemkerian GP. Reddy P, et al. Among authors: kalemkerian gp. J Clin Oncol. 2002 Dec 1;20(23):4597-8. doi: 10.1200/JCO.2002.20.23.4597. J Clin Oncol. 2002. PMID: 12454118 No abstract available.

9

Unusual presentations of lung cancer: Case 2. Adrenal insufficiency as the initial manifestation of non-small-cell lung cancer.

Sirachainan E, Kalemkerian GP. Sirachainan E, et al. Among authors: kalemkerian gp. J Clin Oncol. 2002 Dec 1;20(23):4598-600. doi: 10.1200/JCO.2002.20.23.4598. J Clin Oncol. 2002. PMID: 12454119 No abstract available.

10

False-positive findings with positron emission tomography in the staging of non-small-cell lung cancer.

Schneider BJ, Avram AM, Shulkin BL, Kalemkerian GP. Schneider BJ, et al. Among authors: kalemkerian gp. Clin Adv Hematol Oncol. 2005 Jul;3(7):571-3. Clin Adv Hematol Oncol. 2005. PMID: 16167039 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page